Skip to main content

Morgan Stanley

SEC CIK
0000895421
Latest filing
Aug 13, 2026

HSTO holding history

Histogen Inc. in every 13F filed by Morgan Stanley, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

HSTO overviewAll 13F holders of HSTOFull Q2 2026 holdings

Shares (Q4 2023)
0
Sold out in Q4 2023
Value
$0
% of portfolio
0.0%
Quarters held
8
Since Q1 2021
Holdings of HSTO by Morgan Stanley, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q4 20230$00.0%−8,000−100.0%Sold outHolders
Q3 20238,000$4.12K<0.1%−8,100−50.3%ReducedHolders
Q2 202316,100$11.4K<0.1%+16,100NewHolders
Q4 20220$00.0%−2,575−100.0%Sold outHolders
Q3 20222,575$3.00K<0.1%+2,575NewHolders
Q2 20220$00.0%−109−100.0%Sold outConverted for a 1-for-20 splitHolders
Q1 20222,177$00.0%+2,174+72,466.7%AddedHolders
Q4 20213$00.0%−48−94.1%ReducedHolders
Q3 202151$00.0%+1+2.0%AddedHolders
Q2 202150$00.0%00.0%UnchangedHolders
Q1 202150$00.0%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.